The flat-out denial comes after Cigna CEO David Cordani tried to throw cold water on persistent speculation of a Humana ...

Cigna Group confirmed it is "not pursuing a combination with Humana, a big provider of Medicare Advantage coveage.

The third quarter of 2023 was another mixed bag for major insurers as they continue to grapple with significant headwinds. | ...

Cigna Group reaffirms 2024 EPS outlook, reports strong Q3 results, and clarifies it is not pursuing a merger with Humana amid ...

Cigna subsidiary Evernorth Health Services, Elevance Health subsidiary Carelon and Aetna parent company CVS Health have made big plays into the $400 billion market for medications that are too ...

The remarks on a call with analysts signaled Cigna is focused on returning cash to shareholders rather than a possible deal ...

The courtship between insurance giants Cigna and Humana is just not meant to be, Cigna officials said Monday. Why it matters: ...

On Thursday, Cigna Corporation (NYSE:CI) reported third-quarter sales of $63.7 billion, up 30% year-over-year, beating the ...

Baxter covers the Healthcare sector, focusing on stocks such as Humana, CVS Health, and Centene. Cigna has an analyst consensus of Strong Buy, with a price target consensus of $400.11. CI market cap ...

but we expect potential legislation to be manageable for top-tier players like Cigna, CVS, and UnitedHealth. Medicare Advantage is currently facing many regulatory challenges under the Democratic ...

Three independent pharmacies have filed separate lawsuits accusing GoodRx, which markets a prescription drug discount card, of conspiring with several pharmacy benefit managers to fix ...

CVS Health Corp (NYSE:CVS) reported third-quarter sales of $95.43 billion, beating the consensus of $92.75 billion. Total ...